Any feedback?
Literature summary for 3.4.21.68 extracted from
- Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial) (2010), Am. J. Cardiol., 105, 17-24.
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|
Specific Activity [micromol/min/mg]
| Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
|---|---|---|---|
| additional information | - |
the plasminogen activator inhibitor-1 antigen and its activity and their ratios to tissue-type plasminogen activator are all paradoxically lower with advancing age in patients with type 2 diabetes mellitus, t-PA is significantly and directly associated with increasing age | Homo sapiens |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| t-PA | - |
Homo sapiens |
| t-plasminogen activator | - |
Homo sapiens |
| Tissue-type plasminogen activator | - |
Homo sapiens |
General Information
| General Information | Comment | Organism |
|---|---|---|
| malfunction | the concentrations of t-PA and PAI-1 in the plasma have been identified as variables contributing to the risk of arterial thrombosis | Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
